SCHEMBL5553907

SCHEMBL5553907

Cc1ccc(NC(=O)c2cc(Cl)ccc2N(C=O)c2ccc(C=NN(C)C)cc2)nc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 9/20 0.47
POLB P06746 1/20 0.46
RAB9A P51151 7/20 0.45
KDM4E B2RXH2 3/20 0.45
LMNA P02545 2/20 0.45
ALDH1A1 P00352 2/20 0.43
NPC1 O15118 4/20 0.42
SMN1; SMN2 Q16637 3/20 0.39
MAPT P10636 1/20 0.39
TP53 P04637 2/20 0.39
TSHR P16473 1/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
KCNH2 Q12809 1/20 0.39
KLKB1 P03952 1/20 0.38
ALOX15 P16050 1/20 0.38
HTT P42858 1/20 0.38
GLA P06280 1/20 0.38
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5533696 0.88 F10 (0.49) F10RAB9ANPC1KCNH2KLKB1
SCHEMBL5534106 0.85 F10 (0.42) F10RAB9AKDM4EALDH1A1NPC1
SCHEMBL5536642 0.84 F10 (0.41) F10KCNH2KLKB1
SCHEMBL5549858 0.82 F10 (0.38) F10KCNH2KLKB1
SCHEMBL5553007 0.81 F10 (0.43) F10KCNH2KLKB1
SCHEMBL5534849 0.81 F10 (0.47) F10KCNH2KLKB1
SCHEMBL6841560 0.80 POLB (0.42) F10POLBKDM4ELMNAALDH1A1
SCHEMBL5536431 0.80 F10 (0.46) F10KCNH2KLKB1
SCHEMBL5535739 0.79 F10 (0.46) F10KCNH2KLKB1
SCHEMBL5555100 0.79 F10 (0.46) F10KCNH2KLKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1373194-A1 BENZAMIDE INHIBITORS OF FACTOR Xa Millennium Pharmaceuticals, Inc. (US) 2004-01-02 EP claimed
US-20030069250-A1 Benzamide inhibitors of factor Xa MILLENNIUM PHARMACEUTICALS, INC. 2003-04-10 US claimed
WO-2002079145-A1 BENZAMIDE INHIBITORS OF FACTOR Xa MILLENNIUM PHARMACEUTICALS, INC. (US) 2002-10-10 WO claimed
US-7312235-B2 Benzamide inhibitors of factor Xa MILLENNIUM PHARMACEUTICALS, INC. (US) 2007-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030069250-A1 Benzamide inhibitors of factor Xa SERPINC1, TFPI, F12 F10 10/4885POLB 1818/4885RAB9A 1933/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.